| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| HLN.L - Haleon PLC | BUY | 269,884 @ 4.6888 | 1,265,432 | The ETF bought 269884 new shares of HLN.L (Haleon PLC). The shares were bought for an average price of 4.6888 compared to the previous average buy price of 4.56282. This is 2.8% higher than average price of previous purchases of HLN.L. |
| SAN.PA - Sanofi SA | BUY | 8,719 @ 105.84 | 922,819 | The ETF bought 8719 new shares of SAN.PA (Sanofi SA). The shares were bought for an average price of 105.84 compared to the previous average buy price of 104.5. This is 1.3% higher than average price of previous purchases of SAN.PA. |
| SHL.DE - Siemens Healthineers AG | BUY | 10,109 @ 51.76 | 523,242 | The ETF bought 10109 new shares of SHL.DE (Siemens Healthineers AG). The shares were bought for an average price of 51.76 compared to the previous average buy price of 57.24. This is -9.6% lower than average price of previous purchases of SHL.DE. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | BUY | 4,147 @ 53.45 | 221,657 | The ETF bought 4147 new shares of REC.MI (Recordati Industria Chimica e Farmaceutica SpA). The shares were bought for an average price of 53.45 compared to the previous average buy price of 59.05. This is -9.5% lower than average price of previous purchases of REC.MI. |
| ARGX.BR - Argenx SE | BUY | 115 @ 568.8 | 65,412 | The ETF bought 115 new shares of ARGX.BR (Argenx SE). The shares were bought for an average price of 568.8 compared to the previous average buy price of 619.172. This is -8.1% lower than average price of previous purchases of ARGX.BR. |
| BANB.SW - | HOLD | 0 @ 56.3921 | 0 | |
| BIM.PA - BioMerieux | HOLD | 0 @ 117.6 | 0 | |
| GALD.SW - | HOLD | 0 @ 102.176 | 0 | |
| SFZN.SW - | HOLD | 0 @ 945.628 | 0 | |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ 57.7 | 0 | |
| IPN.PA - Ipsen SA | HOLD | 0 @ 111.1 | 0 | |
| HIK.L - | HOLD | 0 @ 24.1002 | 0 | |
| DEMANT.CO - | HOLD | 0 @ 33.6776 | 0 | |
| AMP.MI - Amplifon SpA | HOLD | 0 @ 19.45 | 0 | |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ 141.6 | 0 | |
| TECN.SW - | HOLD | 0 @ 181.167 | 0 | |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ 94.98 | 0 | |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ 194.8 | 0 | |
| GXI.DE - Gerresheimer AG | HOLD | 0 @ 76.1 | 0 | |
| BAVA.CO - | HOLD | 0 @ 21.8596 | 0 | |
| AFX.DE - Carl Zeiss Meditec AG | HOLD | 0 @ 63.95 | 0 | |
| NSIS-B.CO - | HOLD | 0 @ 53.6804 | 0 | |
| COLO-B.CO - | HOLD | 0 @ 97.3325 | 0 | |
| GETI-B.ST - | HOLD | 0 @ 20.1514 | 0 | |
| ALK-B.CO - | HOLD | 0 @ 19.3727 | 0 | |
| AMBU-B.CO - | HOLD | 0 @ 16.3495 | 0 | |
| EKTA-B.ST - | HOLD | 0 @ 5.12913 | 0 | |
| QIA.DE - QIAGEN NV | HOLD | 0 @ 36.56 | 0 | |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ 3.06622 | 0 | |
| MRK.DE - Merck KGaA | HOLD | 0 @ 131.4 | 0 | |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ 23.6 | 0 | |
| SDZ.SW - | HOLD | 0 @ 39.8253 | 0 | |
| SOON.SW - | HOLD | 0 @ 279.918 | 0 | |
| GMAB.CO - | HOLD | 0 @ 182.8 | 0 | |
| STMN.SW - | HOLD | 0 @ 117.654 | 0 | |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ 45 | 0 | |
| ZEAL.CO - | HOLD | 0 @ 75.6137 | 0 | |
| SOBI.ST - | HOLD | 0 @ 26.5035 | 0 | |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ 51.42 | 0 | |
| SRT3.DE - Sartorius AG | HOLD | 0 @ 233.8 | 0 | |
| BAYN.DE - Bayer AG | SELL | -809 @ 24.08 | -19,481 | The ETF sold 809 shares of BAYN.DE on 2025-03-21. The shares were previously bought for an average price of 20.98. The Bayer AG shares were sold for 14.8% higher than average price of previous purchases. This sale made a profit of 2,508 The average price that the ETF previously sold BAYN.DE share for is 20.77 so the ETF has sold 809 shares on 2025-03-21 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -110 @ 178.75 | -19,663 | The ETF sold 110 shares of UCB.BR on 2025-03-21. The shares were previously bought for an average price of 190.35. The UCB SA shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of 1,276 The average price that the ETF previously sold UCB.BR share for is 173.529 so the ETF has sold 110 shares on 2025-03-21 at a higher price than the previous selling average. |
| SN.L - Smith & Nephew PLC | SELL | -1,520 @ 12.9449 | -19,676 | The ETF sold 1520 shares of SN.L on 2025-03-21. The shares were previously bought for an average price of 12.2191. The Smith & Nephew PLC shares were sold for 5.9% higher than average price of previous purchases. This sale made a profit of 1,103 The average price that the ETF previously sold SN.L share for is 12.0226 so the ETF has sold 1520 shares on 2025-03-21 at a higher price than the previous selling average. |
| GRF.MC - Grifols SA | SELL | -2,774 @ 9.2 | -25,521 |
Deprecated: number_format(): Passing null to parameter #1 ($num) of type float is deprecated in /var/www/liquidata/show_ETF_trades.php on line 108
The ETF sold 2774 shares of GRF.MC on 2025-03-21. The shares were previously bought for an average price of . The Grifols SA shares were sold for 0.0% than average price of previous purchases. The average price that the ETF previously sold GRF.MC share for is 10.895 which is higher than the selling price of 9.2 on 2025-03-21. |
| LONN.SW - | SELL | -47 @ 595.232 | -27,976 | The ETF sold 47 shares of LONN.SW on 2025-03-21. The shares were previously bought for an average price of 631.723. The shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of 1,715 The average price that the ETF previously sold LONN.SW share for is 554.776 so the ETF has sold 47 shares on 2025-03-21 at a higher price than the previous selling average. |
| ALC.SW - | SELL | -341 @ 83.6928 | -28,539 | The ETF sold 341 shares of ALC.SW on 2025-03-21. The shares were previously bought for an average price of 85.3132. The shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of 553 The average price that the ETF previously sold ALC.SW share for is 82.6193 so the ETF has sold 341 shares on 2025-03-21 at a higher price than the previous selling average. |
| SECT-B.ST - | SELL | -1,651 @ 23.2043 | -38,310 | The ETF sold 1651 shares of SECT-B.ST on 2025-03-21. The shares were previously bought for an average price of 21.9981. The shares were sold for 5.5% higher than average price of previous purchases. This sale made a profit of 1,991 The average price that the ETF previously sold SECT-B.ST share for is so the ETF has sold 1651 shares on 2025-03-21 at a higher price than the previous selling average. |
| EL.PA - EssilorLuxottica SA | SELL | -147 @ 267.4 | -39,308 | The ETF sold 147 shares of EL.PA on 2025-03-21. The shares were previously bought for an average price of 276. The EssilorLuxottica SA shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of 1,264 The average price that the ETF previously sold EL.PA share for is 227.521 so the ETF has sold 147 shares on 2025-03-21 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -2,657 @ 18.0036 | -47,836 | The ETF sold 2657 shares of GSK.L on 2025-03-21. The shares were previously bought for an average price of 17.3188. The GlaxoSmithKline PLC shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of 1,820 The average price that the ETF previously sold GSK.L share for is 15.9886 so the ETF has sold 2657 shares on 2025-03-21 at a higher price than the previous selling average. |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -1,802 @ 39.67 | -71,485 | The ETF sold 1802 shares of FRE.DE on 2025-03-21. The shares were previously bought for an average price of 38.18. The Fresenius SE & Co KGaA shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of 2,685 The average price that the ETF previously sold FRE.DE share for is 33.0678 so the ETF has sold 1802 shares on 2025-03-21 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -743 @ 138.493 | -102,900 | The ETF sold 743 shares of AZN.L on 2025-03-21. The shares were previously bought for an average price of 141.451. The AstraZeneca PLC shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of 2,198 The average price that the ETF previously sold AZN.L share for is 123.204 so the ETF has sold 743 shares on 2025-03-21 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -387 @ 323.796 | -125,309 | The ETF sold 387 shares of ROG.SW on 2025-03-21. The shares were previously bought for an average price of 307.841. The shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of 6,175 The average price that the ETF previously sold ROG.SW share for is 274.645 so the ETF has sold 387 shares on 2025-03-21 at a higher price than the previous selling average. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -8,689 @ 70.8945 | -616,002 | The ETF sold 8689 shares of NOVO-B.CO on 2025-03-21. The shares were previously bought for an average price of 78.5252. The Novo Nordisk A/S shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of 66,303 The average price that the ETF previously sold NOVO-B.CO share for is 68.0519 so the ETF has sold 8689 shares on 2025-03-21 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -6,857 @ 103.914 | -712,538 | The ETF sold 6857 shares of NOVN.SW on 2025-03-21. The shares were previously bought for an average price of 103.212. The shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of 4,814 The average price that the ETF previously sold NOVN.SW share for is 96.9871 so the ETF has sold 6857 shares on 2025-03-21 at a higher price than the previous selling average. |